372 related articles for article (PubMed ID: 26964399)
1. [Use of a novel polymer, the in-situ gelling mucoadhesive thiolated poly(aspartic acid) in ophthalmic drug delivery].
Horvát G; Budai-Szűcs M; Berkó S; Szabóné-Révész P; Gyarmati B; Szilágyi BÁ; Szilágyi A; Csányi Erzsébet
Acta Pharm Hung; 2015; 85(4):115-21. PubMed ID: 26964399
[TBL] [Abstract][Full Text] [Related]
2. Thiolated poly(aspartic acid) as potential in situ gelling, ocular mucoadhesive drug delivery system.
Horvát G; Gyarmati B; Berkó S; Szabó-Révész P; Szilágyi BÁ; Szilágyi A; Soós J; Sandri G; Bonferoni MC; Rossi S; Ferrari F; Caramella C; Csányi E; Budai-Szűcs M
Eur J Pharm Sci; 2015 Jan; 67():1-11. PubMed ID: 25445832
[TBL] [Abstract][Full Text] [Related]
3. In vitro testing of thiolated poly(aspartic acid) from ophthalmic formulation aspects.
Budai-Szű Cs M; Horvát G; Gyarmati B; Szilágyi BÁ; Szilágyi A; Csihi T; Berkó S; Szabó-Révész P; Mori M; Sandri G; Bonferoni MC; Caramella C; Csányi E
Drug Dev Ind Pharm; 2016 Aug; 42(8):1241-6. PubMed ID: 26556306
[TBL] [Abstract][Full Text] [Related]
4. Thiolated polymers as mucoadhesive drug delivery systems.
Duggan S; Cummins W; O' Donovan O; Hughes H; Owens E
Eur J Pharm Sci; 2017 Mar; 100():64-78. PubMed ID: 28087353
[TBL] [Abstract][Full Text] [Related]
5. The effect of the antioxidant on the properties of thiolated poly(aspartic acid) polymers in aqueous ocular formulations.
Budai-Szűcs M; Horvát G; Gyarmati B; Szilágyi BÁ; Szilágyi A; Berkó S; Ambrus R; Szabó-Révész P; Sandri G; Bonferoni MC; Caramella C; Csányi E
Eur J Pharm Biopharm; 2017 Apr; 113():178-187. PubMed ID: 28088003
[TBL] [Abstract][Full Text] [Related]
6. S-preactivated thiolated glycol chitosan useful to combine mucoadhesion and drug delivery.
Perrone M; Lopalco A; Lopedota A; Cutrignelli A; Laquintana V; Franco M; Bernkop-Schnürch A; Denora N
Eur J Pharm Biopharm; 2018 Nov; 132():103-111. PubMed ID: 30253185
[TBL] [Abstract][Full Text] [Related]
7. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.
Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V
Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970
[TBL] [Abstract][Full Text] [Related]
8. In situ gelling and mucoadhesive polymers: why do they need each other?
Zahir-Jouzdani F; Wolf JD; Atyabi F; Bernkop-Schnürch A
Expert Opin Drug Deliv; 2018 Oct; 15(10):1007-1019. PubMed ID: 30173567
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterisation of mucoadhesive thiolated polyallylamine.
Duggan S; Hughes H; Owens E; Duggan E; Cummins W; O' Donovan O
Int J Pharm; 2016 Feb; 499(1-2):368-375. PubMed ID: 26792169
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release.
Rupenthal ID; Green CR; Alany RG
Int J Pharm; 2011 Jun; 411(1-2):69-77. PubMed ID: 21453762
[TBL] [Abstract][Full Text] [Related]
11. Mucoadhesive Cyclodextrin-Modified Thiolated Poly(aspartic acid) as a Potential Ophthalmic Drug Delivery System.
Budai-Szűcs M; Kiss EL; Szilágyi BÁ; Szilágyi A; Gyarmati B; Berkó S; Kovács A; Horvát G; Aigner Z; Soós J; Csányi E
Polymers (Basel); 2018 Feb; 10(2):. PubMed ID: 30966235
[TBL] [Abstract][Full Text] [Related]
12. In situ gelation of thiolated poly(aspartic acid) derivatives through oxidant-free disulfide formation for ophthalmic drug delivery.
Szilágyi BÁ; Gyarmati B; Kiss EL; Budai-Szűcs M; Misra A; Csányi E; László K; Szilágyi A
Colloids Surf B Biointerfaces; 2023 May; 225():113254. PubMed ID: 36996632
[TBL] [Abstract][Full Text] [Related]
13. S-protected thiolated hydroxyethyl cellulose (HEC): Novel mucoadhesive excipient with improved stability.
Leonaviciute G; Bonengel S; Mahmood A; Ahmad Idrees M; Bernkop-Schnürch A
Carbohydr Polym; 2016 Jun; 144():514-21. PubMed ID: 27083843
[TBL] [Abstract][Full Text] [Related]
14. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
[TBL] [Abstract][Full Text] [Related]
15. Preactivated hyaluronic acid: A potential mucoadhesive polymer for vaginal delivery.
Nowak J; Laffleur F; Bernkop-Schnürch A
Int J Pharm; 2015 Jan; 478(1):383-389. PubMed ID: 25445990
[TBL] [Abstract][Full Text] [Related]
16. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin.
Qi H; Chen W; Huang C; Li L; Chen C; Li W; Wu C
Int J Pharm; 2007 Jun; 337(1-2):178-87. PubMed ID: 17254725
[TBL] [Abstract][Full Text] [Related]
17. Phenylboronic-Acid-Based Polymeric Micelles for Mucoadhesive Anterior Segment Ocular Drug Delivery.
Prosperi-Porta G; Kedzior S; Muirhead B; Sheardown H
Biomacromolecules; 2016 Apr; 17(4):1449-57. PubMed ID: 26963738
[TBL] [Abstract][Full Text] [Related]
18. Preactivated thiolated pullulan as a versatile excipient for mucosal drug targeting.
Leonaviciute G; Suchaoin W; Matuszczak B; Lam HT; Mahmood A; Bernkop-Schnürch A
Carbohydr Polym; 2016 Oct; 151():743-751. PubMed ID: 27474621
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the mucoadhesive properties of thiolated polyacrylic acid to thiolated polyallylamine.
Duggan S; O'Donovan O; Owens E; Duggan E; Hughes H; Cummins W
Int J Pharm; 2016 Feb; 498(1-2):245-53. PubMed ID: 26705154
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the mucoadhesive properties of drug delivery systems based on hydrated thiolated alginate.
Davidovich-Pinhas M; Harari O; Bianco-Peled H
J Control Release; 2009 May; 136(1):38-44. PubMed ID: 19217920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
